KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Exchange Rate Effect (2016 - 2025)

Nektar Therapeutics has reported Exchange Rate Effect over the past 16 years, most recently at $1000.0 for Q3 2025.

  • Quarterly results put Exchange Rate Effect at $1000.0 for Q3 2025, up 103.57% from a year ago — trailing twelve months through Dec 2025 was $6000.0 (up 250.0% YoY), and the annual figure for FY2025 was $6000.0, up 250.0%.
  • Exchange Rate Effect for Q3 2025 was $1000.0 at Nektar Therapeutics, down from $6000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for NKTR hit a ceiling of $107000.0 in Q2 2023 and a floor of -$295000.0 in Q3 2022.
  • Median Exchange Rate Effect over the past 5 years was -$8000.0 (2024), compared with a mean of -$18684.2.
  • Biggest five-year swings in Exchange Rate Effect: plummeted 1080.0% in 2022 and later soared 700.0% in 2025.
  • Nektar Therapeutics' Exchange Rate Effect stood at -$10000.0 in 2021, then soared by 650.0% to $55000.0 in 2022, then tumbled by 85.45% to $8000.0 in 2023, then surged by 312.5% to $33000.0 in 2024, then tumbled by 96.97% to $1000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $1000.0 (Q3 2025), $6000.0 (Q2 2025), and -$1000.0 (Q1 2025) per Business Quant data.